Tauriga Sciences Inc. Enters First Distribution Agreement For Natural Medicine Products

Tauriga Sciences, Inc.


Share Tweet

Tauriga Sciences Inc. Enters First Distribution Agreement For Natural Medicine Products

LOS ANGELES / ACCESSWIRE / May 29, 2014 / Tauriga Sciences Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with a proprietary microbial fuel cell technology and a pending acquisition in the medicinal cannabis space, has entered into its first retail distribution agreement for its new line of natural medicine products. Tauriga's natural medicine product line is expected to launch this summer and will include non-cannabis containing candies, gums and supplements with proprietary formulations designed to address unwanted cannabis-related effects such as increased appetite, anxiety, and reduction in memory and cognitive function. The Company's first retail distribution agreement for these products is with SpeedWeed, a leading medical marijuana delivery service serving areas of Southern California in strict accordance with California regulations and health and safety codes.

Tauriga's cannabis-free natural medicine products have been developed for medical marijuana patients by Dr. Lawrence May, Tauriga's Chief Medical Officer and former Executive Vice President and Chairman of the Medical Advisory Board of Herbalife International. Dr. May states, "We believe that there is an important market need for premium natural health care products for the growing population of legitimate marijuana patients. Tauriga's new product line uses ingredients that are classified as 'generally recognized as safe' (GRAS) and that are supported by scientific and clinical literature."

SpeedWeed founder and CEO, A.J. Gentile, added, "We are pleased to serve as a retail distributor and test market for Tauriga's innovative natural medicine products. We believe these products can improve the experiential component for our clients, and our ability to offer new ancillary products is another example of our commitment to customer service. We look forward to further developing our relationship with Tauriga as we continue to grow our customer base with high customer ratings."

Tauriga plans to increase its presence in the overall natural medicine sector beyond medicinal cannabis-containing products. Company Chairman & CEO, Dr. Stella M. Sung states, "Ultimately, we hope to launch an integrated family of natural health care products that will improve the overall experience of the medical marijuana patient and encourage them to use medical marijuana responsibly. Furthermore, we believe our non-cannabis products may be sold through many different channels, which will potentially allow us to more quickly access markets and early revenues."

About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc.
(TAUG) is a diversified life sciences company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. On March 10, 2014, Tauriga signed a definitive agreement to acquire a California based topical cannabis cream company. Please visit the Company's corporate website atwww.tauriga.com.

About SpeedWeed:
SpeedWeed is the largest on-demand cannabis delivery service in Southern California. By harnessing technology and leveraging partnerships with industry leaders, SpeedWeed provides thousands of patients safe, legal access to an unmatched selection of cannabis and non-cannabis products.

SpeedWeed operates as a non-profit co-operative corporation in accordance with California Health and Safety Code Sec. 11362.5(B)(1)(A) & 11362.7(H) Prop 215 & S.B 420. SpeedWeed has been featured on HBO: VICE, This Week in Startups, MTV, TMZ, CNBC, Sports Illustrated and other media. Please visit the SpeedWeed website http://www.speedweed.com for more information.

Please visit the SpeedWeed website at http://www.speedweed.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.

Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent
events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.

Tauriga Sciences, Inc.:
Dr. Stella M. Sung,

Chairman and Chief Executive Officer
Tauriga Sciences, Inc.
San Diego: + 1-858-353-5749
Montreal: + 1-514-840-3697
Email: [email protected]


SOURCE: Tauriga Sciences Inc.